CDK4 and neoplasm: Zhang et al. suggested that CDK4 negatively regulates programmed cell death ligand 1 (PD-L1) protein stability; moreover, CDK4 and PD-L1 levels negatively correlate with tumor treatment (Scheicher et al., 2015; Goel et al., 2017).